BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 12682637)

  • 1. A flow cytometric method to detect apoptosis-related protein expression in minimal residual disease in acute myeloid leukemia.
    van Stijn A; Kok A; van der Pol MA; Feller N; Roemen GM; Westra AH; Ossenkoppele GJ; Schuurhuis GJ
    Leukemia; 2003 Apr; 17(4):780-6. PubMed ID: 12682637
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multiparameter flow cytometric quantification of apoptosis-related protein expression.
    van Stijn A; Kok A; van der Pol MA; Feller N; Roemen GM; Westra AH; Ossenkoppele GJ; Schuurhuis GJ
    Leukemia; 2003 Apr; 17(4):787-8. PubMed ID: 12682638
    [No Abstract]   [Full Text] [Related]  

  • 3. Minimal residual disease in acute myeloid leukemia is predicted by an apoptosis-resistant protein profile at diagnosis.
    van Stijn A; Feller N; Kok A; van der Pol MA; Ossenkoppele GJ; Schuurhuis GJ
    Clin Cancer Res; 2005 Apr; 11(7):2540-6. PubMed ID: 15814631
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differences between the CD34+ and CD34- blast compartments in apoptosis resistance in acute myeloid leukemia.
    van Stijn A; van der Pol MA; Kok A; Bontje PM; Roemen GM; Beelen RH; Ossenkoppele GJ; Schuurhuis GJ
    Haematologica; 2003 May; 88(5):497-508. PubMed ID: 12745269
    [TBL] [Abstract][Full Text] [Related]  

  • 5. miR-10a overexpression is associated with NPM1 mutations and MDM4 downregulation in intermediate-risk acute myeloid leukemia.
    Ovcharenko D; Stölzel F; Poitz D; Fierro F; Schaich M; Neubauer A; Kelnar K; Davison T; Müller-Tidow C; Thiede C; Bornhäuser M; Ehninger G; Brown D; Illmer T
    Exp Hematol; 2011 Oct; 39(10):1030-1042.e7. PubMed ID: 21784052
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of BCL-2 and bax protein in monocyte-mediated apoptosis in human leukemic cell lines.
    Legdeur MC; Bontje PM; Ossenkoppele GJ; Beelen RH; van de Loosdrecht AA; Broekhoven MG; Langenhuijsen MM; Thijsen SF; Hofstee H; Schuurhuis GJ
    Exp Hematol; 1996 Nov; 24(13):1530-9. PubMed ID: 8950237
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Flt3 ligand stimulates proliferation and inhibits apoptosis of acute myeloid leukemia cells: regulation of Bcl-2 and Bax.
    Lisovsky M; Estrov Z; Zhang X; Consoli U; Sanchez-Williams G; Snell V; Munker R; Goodacre A; Savchenko V; Andreeff M
    Blood; 1996 Nov; 88(10):3987-97. PubMed ID: 8916965
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The impact of cell heterogeneity and immunophenotypic changes on monitoring minimal residual disease in acute myeloid leukemia.
    Zelezníková T; Babusíková O
    Neoplasma; 2006; 53(6):500-6. PubMed ID: 17167719
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD34+ cells from acute myeloid leukemia, myelodysplastic syndromes, and normal bone marrow display different apoptosis and drug resistance-associated phenotypes.
    Suárez L; Vidriales MB; García-Laraña J; Sanz G; Moreno MJ; López A; Barrena S; Martínez R; Tormo M; Palomera L; Lavilla E; López-Berges MC; de Santiago M; de Equiza ME; Miguel JF; Orfao A
    Clin Cancer Res; 2004 Nov; 10(22):7599-606. PubMed ID: 15569991
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of bcl-2, bcl-XL and bax in the control of apoptosis by hematopoietic cytokines and dexamethasone.
    Lotem J; Sachs L
    Cell Growth Differ; 1995 Jun; 6(6):647-53. PubMed ID: 7669718
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of Bcl-2-related genes in normal and AML progenitors: changes induced by chemotherapy and retinoic acid.
    Andreeff M; Jiang S; Zhang X; Konopleva M; Estrov Z; Snell VE; Xie Z; Okcu MF; Sanchez-Williams G; Dong J; Estey EH; Champlin RC; Kornblau SM; Reed JC; Zhao S
    Leukemia; 1999 Nov; 13(11):1881-92. PubMed ID: 10557066
    [TBL] [Abstract][Full Text] [Related]  

  • 12. p53 pathway in apoptosis induced by all-trans-retinoic acid in acute myeloblastic leukaemia cells.
    Zheng A; Mäntymaa P; Säily M; Savolainen E; Vähäkangas K; Koistinen P
    Acta Haematol; 2000; 103(3):135-43. PubMed ID: 10940651
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional characterization of minimal residual disease for P-glycoprotein and multidrug resistance protein activity in acute myeloid leukemia.
    van der Pol MA; Pater JM; Feller N; Westra AH; van Stijn A; Ossenkoppele GJ; Broxterman HJ; Schuurhuis GJ
    Leukemia; 2001 Oct; 15(10):1554-63. PubMed ID: 11587213
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stromal cells prevent apoptosis of AML cells by up-regulation of anti-apoptotic proteins.
    Konopleva M; Konoplev S; Hu W; Zaritskey AY; Afanasiev BV; Andreeff M
    Leukemia; 2002 Sep; 16(9):1713-24. PubMed ID: 12200686
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The prognostic value of Bcl-XL gene expression for remission induction is influenced by cytogenetics in adult acute myeloid leukemia.
    Schaich M; Illmer T; Seitz G; Mohr B; Schäkel U; Beck JF; Ehninger G
    Haematologica; 2001 May; 86(5):470-7. PubMed ID: 11410409
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multiparametric analysis of apoptotic and multi-drug resistance phenotypes according to the blast cell maturation stage in elderly patients with acute myeloid leukemia.
    Suárez L; Vidriales B; García-Laraña J; López A; Martínez R; Martín-Reina V; Tormo M; González-San Miguel JD; Lavilla E; García-Boyero R; Orfao A; San Miguel JF;
    Haematologica; 2001 Dec; 86(12):1287-95. PubMed ID: 11726321
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High expression levels of x-linked inhibitor of apoptosis protein and survivin correlate with poor overall survival in childhood de novo acute myeloid leukemia.
    Tamm I; Richter S; Oltersdorf D; Creutzig U; Harbott J; Scholz F; Karawajew L; Ludwig WD; Wuchter C
    Clin Cancer Res; 2004 Jun; 10(11):3737-44. PubMed ID: 15173080
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ajoene, a garlic-derived natural compound, enhances chemotherapy-induced apoptosis in human myeloid leukaemia CD34-positive resistant cells.
    Ahmed N; Laverick L; Sammons J; Zhang H; Maslin DJ; Hassan HT
    Anticancer Res; 2001; 21(5):3519-23. PubMed ID: 11848518
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Minimal residual disease cells in AML patients have an apoptosis-sensitive protein profile.
    van Stijn A; Kok A; van Stalborch MA; van Der Pol MA; Feller N; Westra AH; Ossenkoppele GJ; Schuurhuis GJ
    Leukemia; 2004 Apr; 18(4):875-7. PubMed ID: 14762445
    [No Abstract]   [Full Text] [Related]  

  • 20. Apoptosis and expression of apoptosis regulating proteins bcl-2, mcl-1, bcl-X, and bax in malignant mesothelioma.
    Soini Y; Kinnula V; Kaarteenaho-Wiik R; Kurttila E; Linnainmaa K; Pääkkö P
    Clin Cancer Res; 1999 Nov; 5(11):3508-15. PubMed ID: 10589765
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.